175 related articles for article (PubMed ID: 10210211)
1. Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas.
Gibril F; Reynolds JC; Chen CC; Yu F; Goebel SU; Serrano J; Doppman JL; Jensen RT
J Nucl Med; 1999 Apr; 40(4):539-53. PubMed ID: 10210211
[TBL] [Abstract][Full Text] [Related]
2. Making the best of imperfect tumor-localizing radiopharmaceuticals.
Shapiro B; Gross MD
J Nucl Med; 1999 Apr; 40(4):554-5. PubMed ID: 10210212
[No Abstract] [Full Text] [Related]
3. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
[TBL] [Abstract][Full Text] [Related]
4. Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management.
Gibril F; Doppman JL; Reynolds JC; Chen CC; Sutliff VE; Yu F; Serrano J; Venzon DJ; Jensen RT
J Clin Oncol; 1998 Mar; 16(3):1040-53. PubMed ID: 9508189
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.
Gibril F; Reynolds JC; Doppman JL; Chen CC; Venzon DJ; Termanini B; Weber HC; Stewart CA; Jensen RT
Ann Intern Med; 1996 Jul; 125(1):26-34. PubMed ID: 8644985
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
Lebtahi R; Cadiot G; Sarda L; Daou D; Faraggi M; Petegnief Y; Mignon M; le Guludec D
J Nucl Med; 1997 Jun; 38(6):853-8. PubMed ID: 9189129
[TBL] [Abstract][Full Text] [Related]
7. Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: a prospective study.
Gibril F; Reynolds JC; Lubensky IA; Roy PK; Peghini PL; Doppman JL; Jensen RT
J Nucl Med; 2000 Oct; 41(10):1646-56. PubMed ID: 11037994
[TBL] [Abstract][Full Text] [Related]
8. False-positive somatostatin receptor scintigraphy due to an accessory spleen.
Lebtahi R; Cadiot G; Marmuse JP; Vissuzaine C; Petegnief Y; Courillon-Mallet A; Cattan D; Mignon M; Le Guludec D
J Nucl Med; 1997 Dec; 38(12):1979-81. PubMed ID: 9430481
[TBL] [Abstract][Full Text] [Related]
9. Definition of the role of somatostatin receptor scintigraphy in gastrointestinal neuroendocrine tumor localization.
Jensen RT; Gibril F; Termanini B
Yale J Biol Med; 1997; 70(5-6):481-500. PubMed ID: 9825476
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor scintigraphy in gastrinomas.
Jensen RT; Gibril F
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S179-85. PubMed ID: 10604126
[TBL] [Abstract][Full Text] [Related]
12. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
Lebtahi R; Cadiot G; Delahaye N; Genin R; Daou D; Peker MC; Chosidow D; Faraggi M; Mignon M; Le Guludec D
J Nucl Med; 1999 Oct; 40(10):1602-8. PubMed ID: 10520698
[TBL] [Abstract][Full Text] [Related]
13. Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management.
Termanini B; Gibril F; Reynolds JC; Doppman JL; Chen CC; Stewart CA; Sutliff VE; Jensen RT
Gastroenterology; 1997 Feb; 112(2):335-47. PubMed ID: 9024287
[TBL] [Abstract][Full Text] [Related]
14. [Somatostatin receptor scintigraphy in the primary diagnosis and follow-up care of gastrinoma].
Höring E; Räth U; Rücker S; von Gaisberg U; Meincke J; Walendzik J; Dörr U; Bihl H
Dtsch Med Wochenschr; 1994 Mar; 119(11):367-74. PubMed ID: 8131715
[TBL] [Abstract][Full Text] [Related]
15. Zollinger-Ellison syndrome: prospective assessment of abdominal US in the localization of gastrinomas.
London JF; Shawker TH; Doppman JL; Frucht HH; Vinayek R; Stark HA; Miller LS; Miller DL; Norton JA; Jensen RT
Radiology; 1991 Mar; 178(3):763-7. PubMed ID: 1994415
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison.
de Kerviler E; Cadiot G; Lebtahi R; Faraggi M; Le Guludec D; Mignon M
Eur J Nucl Med; 1994 Nov; 21(11):1191-7. PubMed ID: 7859770
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing small hepatic hemangiomas from vascular liver metastases in gastrinoma: use of a somatostatin-receptor scintigraphic agent.
Termanini B; Gibril F; Doppman JL; Reynolds JC; Stewart CA; Sutliff VE; Venzon DJ; Jensen RT
Radiology; 1997 Jan; 202(1):151-8. PubMed ID: 8988205
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).
Cadiot G; Bonnaud G; Lebtahi R; Sarda L; Ruszniewski P; Le Guludec D; Mignon M
Gut; 1997 Jul; 41(1):107-14. PubMed ID: 9274481
[TBL] [Abstract][Full Text] [Related]
19. What is a false-positive somatostatin receptor scintigraphy?
Reubi JC
J Nucl Med; 1998 Dec; 39(12):2193-4. PubMed ID: 9867170
[No Abstract] [Full Text] [Related]
20. Gastrinoma: advances in localization and treatment.
Norton JA
Surg Oncol Clin N Am; 1998 Oct; 7(4):845-61. PubMed ID: 9735137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
